High-throughput drug screening system and method
A high-throughput, drug-based technology, applied in biochemical equipment and methods, chemical instruments and methods, biomass post-processing, etc., can solve the problems of application limitations, lower liquid flow velocity, and low efficiency of concentration gradient generation, and achieve The effect of reducing the number of layers of the flow channel structure, increasing the fluid flow rate, and improving the generation efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0084] refer to Figure 1-2 , a high-throughput drug screening system of the present embodiment, comprising:
[0085] The microfluidic chip 1 has a microfluidic channel structure 2 on it, and the microfluidic channel structure 2 includes a drug primary screening structure 20 and a drug fine screening structure 21, and the drug primary screening structure 20 is used to screen out pairs of drugs from different types of drugs. Candidate drugs with effects on target cells, the fine drug screening structure 21 is used to analyze and judge the effects of candidate drugs at different concentrations;
[0086] Optical detection module 7, which is used for optical detection of the reaction system in the drug primary screening structure 20 and the drug fine screening structure 21, to judge the effect of the drug;
[0087] The cultivation module is used to provide the required cultivation environment for the reaction system in the primary drug screening structure 20 and the fine drug scr...
Embodiment 2
[0112] refer to Figure 2-7 , as a further improvement on the basis of the above embodiment, in this embodiment, the fine drug screening structure 21 also includes a mixing unit 4 arranged between the concentration gradient generation unit 3 and the cell culture unit 5;
[0113] The concentration gradient generating unit 3 includes a gradient generating structure 30 and a concentration configuration structure 3131. The gradient generating structure 30 includes a selected drug inlet 300, a first distribution channel group 302 communicating with the selected drug inlet 300, and a channel group 302 connected to the first configuration. Several second distribution channel groups 304 connected by channel groups;
[0114] The first distribution channel group 302 includes N first distribution channels 3020 arranged at intervals along the Y direction, the first distribution channels 3020 are parallel to the X direction, and the lengths of all the first distribution channels 3020 are e...
Embodiment 3
[0150] refer to Figure 2-9 In this embodiment, N=3, M=3 (that is, the number of first distribution channels 3020 is 3, the number of second distribution channels 3040 is 9, and 9 concentration gradients can be generated) as a specific example for description.
[0151] In this embodiment, the width range of the channels in the first distribution channel group 302 is 50-1500 μm, and the depth range is 2-20 μm; the width range of the channels in the second distribution channel 3040 is 30-200 μm, and the depth range is 2-20 μm. 25 μm.
[0152] In one embodiment, the numbers are sequentially numbered from top to bottom, and the volumes of the 1st to 3rd first distribution channels 3020 are U 0 , 3U 0 、9U 0 , the volumes of the three second distribution channels 3040 connected after each first distribution channel 3020 are V from top to bottom 0 , 1.5V 0 , 2V 0 , that is, the volume ratio of the three second distribution channels 3040 in each second distribution channel group...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


